This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Formation | 1997 |
---|---|
Headquarters | Leuven, Belgium |
Membership |
|
President | Alain Bron |
Website | www |
The European Association for Vision and Eye Research is a multidisciplinary scientific society that aims to encourage research and the dissemination of knowledge concerning the eye and vision by means of meetings, publications and exchange of information. It is an international non-profit association formed in agreement with the Belgian law. EVER is the largest European research association that covers all areas of ophthalmology and the vision science. The association currently has members from over 48 countries within Europe and abroad, and is organized in 11 scientific sections.
EVER was founded in 1997 in Montpellier, France, when The Association for Eye Research (AER), the European Community Ophthalmic Research Association (ECORA) and the Joint European Meetings in Ophthalmology and Vision (JERMOV) merged, and recognized by the Belgian Royal Decree on 20 September 1998.
EVER arranges its annual congress at the end of September or the beginning of October at a location close to the Mediterranean. The current location since 2012 has been Nice, France. Previously, the association has met in Palma de Mallorca, Spain, in 1998–2000, Alicante, Spain, in 2001–2003, Vilamoura, Portugal, in 2004–2006, Portoroz, Slovenia, in 2007–2009 and Crete, Greece, in 2010–2011. Central events include free papers, special interest symposia, and keynote lectures. The association collaborates with other societies in the same field and some of these convene annually with EVER.
Membership is open to individuals of any nationality. Engagement or an interest in ophthalmic and vision research is required. A category for members-in-training also exists.
The association is governed by its general assembly and board, which are chaired by its president, according to its statutes and bye-laws. The members of the board are elected from and by the effective members of the association. The board has an executive council with a president, secretary general, treasurer, program secretary, president elect, vice president, vice president elect, past president (ex officio), and EVER Foundation liaison (ex officio), and the chairs of the 11 scientific sections:
Board members are elected for five years. In case none of the elected board members has the Belgian nationality, the board will immediately co-opt a supplementary board member of Belgian nationality. At the end of their term of office, board members are eligible to become president or vice president of the association for a term of one year. The president, the vice-president and the program secretary are appointed by the board.
The past presidents of EVER are:
|
|
The current board members are: [1]
The official journal of EVER is Acta Ophthalmologica since April 2006. [2] Since 2006, the EVER board and the board of the Acta Ophthalmologica Scandinavica Foundation have jointly organized an annual EVER-Acta Lecture at the time of the annual congress of EVER. The speaker is chosen in alternate years by the EVER board and the Acta board, and is honored with the EVER-Acta Silver Medal. The recipients of this medal and their keynote lecture topics so far are:
|
Vision science is the scientific study of visual perception. Researchers in vision science can be called vision scientists, especially if their research spans some of the science's many disciplines.
Hamid Ahmadieh is an Iranian ophthalmologist, medical scientist, and pioneer specializing on the retina of the eye. He is also the founder of Iranian Vitreoretina Society.
Zeynel A. Karcioglu is a medical and surgical practitioner, researcher and medical educator. He is a diplomate of the American Board of Ophthalmology, specializing in Ophthalmic Oncology and Pathology particularly in areas of retinoblastoma, external eye tumors, and primary and metastatic orbital neoplasms. Karcioglu is also residency and fellowship trained in Anatomic Pathology and Neuropathology and certified by the American Board of Pathology.
Acta Ophthalmologica is a peer-reviewed academic, medical journal of ophthalmology established in 1923. The journal is edited by Kai Kaarniranta and Einar Stefánsson and is published 8 times per year by John Wiley & Sons on behalf of the Acta Ophthalmologica Scandinavica Foundation. It is the official journal of the five Nordic Ophthalmological Societies as well as of the European Association for Vision and Eye Research and the Dutch Ophthalmological Society. Supplement issues, as well special issues for doctoral theses, are published along with the main journal.
The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Peter Wiedemann is a German ophthalmologist, specialist in medical and surgical retina and was head at the Department of Ophthalmology at the Leipzig University, Germany, from 1993 to 2021.
Gullapalli Nageswara Rao is an Indian ophthalmologist, the chairman of the Academia Ophthalmologica Internationalis (AOI) and the founder of the L. V. Prasad Eye Institute, Hyderabad. A former associate professor at the School of Medicine and Dentistry of the University of Rochester, Rao is a Fellow of the National Academy of Medical Sciences, India. He was honored by the Government of India, in 2002, with the fourth highest Indian civilian award of Padma Shri. He was elected in 2017 to the Ophthalmology Hall of Fame instituted by the American Society of Cataract and Refractive Surgery.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Berthold Seitz is a German ophthalmologist, professor and director of the Department of Ophthalmology at the Saarland University Medical Center in Homburg, Saarland. He is known for his scientific contributions in the fields of cornea transplantation, cataract surgery and artificial lens-calculation after refractive corneal surgery as well as techniques of amniotic membrane transplantation and its histological integration patterns in the cornea.
Émile Jules Marie Joseph François was a Belgian ophthalmologist.
Virender Singh Sangwan is an Indian ophthalmologist and the Dr. Paul Dubord Chair professor and director of the L. V. Prasad Eye Institute, Hyderabad. Known for his research on limbal stem cells, Sangwan is the founder secretary and an adviser of the Uveitis Society of India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2006.
Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.
The European Ophthalmic Pathology Society is a learned society for advancing ophthalmic pathology, the study of the pathological basis of the diseases of the eye and its adnexa: the orbit, eyelids, conjunctiva and the lacrimal apparatus.
John Gustaf Lindberg was a Finnish ophthalmologist who was the first to describe exfoliation syndrome, an age-related degenerative disease of the eye that often complicates glaucoma and cataract surgery, in his doctoral thesis that he wrote in St. Petersburg and defended in March 1917 in Helsinki, Finland, at that time a Grand Duchy in the Russian Empire.
Henry (Harry) Moss Traquair, FRSE, PRCSE was a Scottish ophthalmic surgeon who made important contributions to the science of perimetry and the use of visual field testing in the diagnosis of disease. He was President of the Royal College of Surgeons of Edinburgh in 1939/40 and President of the Ophthalmological Society of the United Kingdom.
Dimitri Azar is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.
Sundaram Natarajan is an Indian ophthalmologist. In 2002, he started a free clinic in Dharavi, a slum in Mumbai, and treated more than 8,000 people. He has also held free camps in various other suburbs of Mumbai such as Mankhurd and Govandi to treat the economically poor. In 2016, he also held a camp in Kashmir to operate and cure the victims of pellet gun firings.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health, educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 392 peer-reviewed articles, and wrote 23 books and 70 book chapters. As of 2021, he holds two patents. Harris sits on the Board of Directors and the Scientific Advisory Board of The Glaucoma Foundation and is the Vice Chair of International Research and Academic Affairs, co-director of the Center for Ophthalmic Artificial Intelligence and Human Health at Mount Sinai Hospital, and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai.